.png)
Members of the pharmaceutical industry in China are invited to join the BioNTech China R&D Day to discuss emerging immuno-oncology approaches that have the potential to address the fundamental challenges of treating cancer. The scientific event will take place in person or via webcast. Please register to secure your place on site at The Langham Hotel Xintiandi in Shanghai or to listen to the webcast. This event is limited to academic exchanges and discussion of scientific research results.
The Langham Hotel,Xintiandi, Shanghai
13:30 - 19:00 CST31 August 2024
English(Chinese translation)
Agenda
 |
Generic |  |
Presentation |  |
Panel discussion |
|
13:30 14:00 |
|
Check-In |
|
|
14:00 14:40 |
|
Welcome and opening keynote Prof. Ugur Sahin, M.D. |
|
|
14:40 15:30 |
|
Fostering strong research partnerships: How to drive innovation together |
|
|
Xiaolin Liu Chairman, Co-Founder and CEO, Biotheus Chairman, Founder and CEO, MediLink John Zhu, Ph.D. Founder and CEO, DualityBiologics |
Prof. Ugur Sahin, M.D. CEO and Co-Founder, BioNTech Jing He Senior Director External Innovations, BioNTech |
||
|
15:30 16:00 |
Coffee Break | ||
|
16:00 16:20 |
Emerging ADCs and next generation Immuno-modulators in lung cancer Prof. Caicun Zhou, Ph.D., M.D. |
||
|
16:20 16:40 |
ADCs in breast cancer Prof. Jian Zhang, M.D. |
||
|
16:40 17:20 |
Combination Therapy of ADCs + Immuno-modulators |
||
|
Prof. Caicun Zhou, Ph.D., M.D. Shanghai East Hospital Fudan University Shanghai Cancer Center |
Prof. Ugur Sahin, M.D. CEO and Co-Founder, BioNTech Paul Panorchan, Ph.D. Vice President Head of Clinical Pharmacology & Pharmacometrics, BioNTech |
||
|
17:20 19:00 |
Reception | ||
We look forward to welcoming you to the BioNTech China R&D Day.
Do you have any questions? Email researchday@biontech.com.